PLx Pharma is a commercial-stage drug delivery platform technology company focused on improving how and where active pharmaceutical ingredients are absorbed in the gastrointestinal tract via its clinically-validated and patent-protected PLxGuard™ technology. Co. has two Food and Drug Administration approved products, VAZALORE® 81 mg and VAZALORE® 325 mg, which are liquid-filled aspirin capsules for over-the-counter distribution. The complex inside the capsule allows for targeted release of aspirin, limiting its direct contact with the stomach lining. VAZALORE delivers absorption for pain relief plus the lifesaving benefits of aspirin. We show 29 historical shares outstanding datapoints in our PLXP shares outstanding history coverage, used to compute PLXP market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing PLXP market cap history over the course of time is important for investors
interested in comparing PLXP's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of PLXP versus a peer is one thing; comparing
PLXP market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like PLXP can fluctuate over the course of history.
With this page we aim to empower investors researching PLXP by allowing them to research the PLXP market cap history. |
Free PLXP Email Alerts:
Video: The Importance of Market Cap
